NURS 3011 Integrated Pathophysiology/Pharmacology I Exam 1 Blueprint PDF
Document Details
Uploaded by Deleted User
Tags
Summary
This document is a blueprint for a pathophysiology and pharmacology exam, outlining the course content, learning objectives, and specific topics covered. It lists the concepts and their corresponding learning outcomes and specific content to be covered.
Full Transcript
**Content** **Number of Questions** - Introduction to Pathophysiology & Pharmacology - Cellular Adaptation & Homeostasis **\~25** - Immunity, Inflammation, & Infection **\~25** **Total:** **50** [General information:] There will be 50 items on the test. Please use the posted lesson pl...
**Content** **Number of Questions** - Introduction to Pathophysiology & Pharmacology - Cellular Adaptation & Homeostasis **\~25** - Immunity, Inflammation, & Infection **\~25** **Total:** **50** [General information:] There will be 50 items on the test. Please use the posted lesson plans to organize your study and use the information in the power points, mini lecture recordings, and textbook readings as resources for preparation for the exam. Refer to your textbooks for specific questions that arise from either the lesson plans or the mini lectures. **To prepare for pathophysiology, be sure you understand the following information for each disorder: etiology and risk factors, pathophysiology process including compensatory mechanisms, manifestations, complications, and diagnosis**. **For the medications, be sure you understand the following information: desired action, major contraindications, drug-to-drug or food-to-drug interactions (discussed during class if applicable), primary adverse effects, and nursing considerations.** +-----------------------------------+-----------------------------------+ | **Introduction to Pathophysiology | | | & Pharmacology** | | +===================================+===================================+ | | **Specific Content** | +-----------------------------------+-----------------------------------+ | | Primary, Secondary and Tertiary | | | prevention | +-----------------------------------+-----------------------------------+ | | Etiology | | | | | | Pathogenesis | | | | | | Clinical Manifestations | | | | | | Diagnosis | | | | | | Clinical Course | +-----------------------------------+-----------------------------------+ | | Effectiveness of drug therapy | +-----------------------------------+-----------------------------------+ | | Prescription vs over-the-counter; | | | generic vs brand/trade; | | | controlled substances; pregnancy | | | risk) | | | | | | *Figure 1-3* | +-----------------------------------+-----------------------------------+ | | Regulation of drugs | +-----------------------------------+-----------------------------------+ | | Food-drug interaction | | | | | | Drug- drug interaction | +-----------------------------------+-----------------------------------+ | | LADME | | | | | | Describe the four ways in which a | | | drug works of the body | +-----------------------------------+-----------------------------------+ | | Critical Concentration and | | | Therapeutic Index | +-----------------------------------+-----------------------------------+ | | Drug interactions | +-----------------------------------+-----------------------------------+ | | *Box 1.1* FDA Pregnancy | | | Categories | +-----------------------------------+-----------------------------------+ | | Pharmacogenomics | | | | | | Box 2.3 | +-----------------------------------+-----------------------------------+ | | | +-----------------------------------+-----------------------------------+ | | **Specific Content** | +-----------------------------------+-----------------------------------+ | | Causes of cellular injury and | | | cellular death | +-----------------------------------+-----------------------------------+ | | Hypoxic cell injury | +-----------------------------------+-----------------------------------+ | | Cellular adaptions | | | | | | Fig 3-1 | +-----------------------------------+-----------------------------------+ | | Loss of homeostasis | +-----------------------------------+-----------------------------------+ | | Patterns of reversible cell | | | injury | +-----------------------------------+-----------------------------------+ | | Homeostasis | | | | | | Negative feedback system | +-----------------------------------+-----------------------------------+ | | Sympathetic response | | | | | | Parasympathetic response | +-----------------------------------+-----------------------------------+ | | Allostatic Load | +-----------------------------------+-----------------------------------+ | | | +-----------------------------------+-----------------------------------+ | | **Specific Content** | +-----------------------------------+-----------------------------------+ | | Acute inflammation process | | | | | | Cardinal manifestations of | | | inflammation | +-----------------------------------+-----------------------------------+ | | Histamine | | | | | | Prostaglandins | +-----------------------------------+-----------------------------------+ | | Systemic acute-phase response | +-----------------------------------+-----------------------------------+ | | Ulcerative colitis | | | | | | Crohn's Disease | +-----------------------------------+-----------------------------------+ | | Salicylates(aspirin) | | | | | | Acetaminophen (Tylenol) | | | | | | NSAIDS | | | | | | Corticosteroid | +-----------------------------------+-----------------------------------+ | | Colonization v Infection | +-----------------------------------+-----------------------------------+ | | Portal of entry | | | | | | Penetration, direct contact, | | | ingestion, and inhalation. | +-----------------------------------+-----------------------------------+ | | Broad -spectrum v Narrow Spectrum | | | | | | Antibiotic medication table | +-----------------------------------+-----------------------------------+ | | Fig. 11-10 | +-----------------------------------+-----------------------------------+ | | Primary humoral response vs | | | Secondary humoral response | | | | | | Antibodies aka Igs | +-----------------------------------+-----------------------------------+ | | Type I, Type II, Type III, Type | | | IV | +-----------------------------------+-----------------------------------+ | | Genetic versus acquired | | | immunodeficiency | +-----------------------------------+-----------------------------------+
